HEPATITIS C
Abbott RealTime HCV
For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
For HCV management, especially given the high cost of therapies, excellent performance at clinical decision points is critical for providing reliable results (at 25 IU/ML) to assess SVR. The Abbott RealTime HCV assay delivers accurate quantification of GT 1-6 using human serum, plasma, and now also available for Dried Blood Spot (DBS) sample .
To learn more about the Abbott RealTime HCV please visit: https://www.molecular.abbott/int/en/products/infectious-disease/realtime-hcv-viral-load
| ABBOTT REALTIME HCV PERFORMANCE* | |
| Sensitivity | 462 IU/mL for the 70 µL sample volume (DBS) 12 IU/mL for the 500 µL sample volume (Plasma/Serum) 30 IU/mL for the 200 µL sample volume (Plasma/Serum) |
| Linear Range | 462 IU/mL to 1.0E+08 IU/mL (DBS) 12 IU/mL to 1.0E+08 IU/mL (500 µL Plasma/Serum) 30 IU/mL to 1.0E+08 IU/mL (200 µL Plasma/Serum) |
| Precision | ≤ 0.25 log IU/mL SD from 1.0E+04 to 1.0E+08 IU/mL (DBS) ≤ 0.25 log IU/mL SD from 100 to 1.0E+08 IU/mL (Plasma/Serum) |
| Specificity | Overall: 100% |
| Genotype Detection | Accurate quantification of genotypes 1, 2, 3, 4, 5 and 6 |
| Standardization | Second World Health Organization international standard for HCV RNA (NIBSC 96/798) |
| Internal Control | Armored RND (Pumpkin kinase) |
| Calibrator | 2 Calibrator levels - single use tubes |
| Control | One negative, one low positive and one high positive control |
*Abbott RealTime HCV Package Insert 51-602124/R12 and Abbott Realtime HCV with DBS Package Insert 51-608440/R1.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.